Predict your next investment

Deep Lens company logo
INTERNET | Internet Software & Services / Healthcare
deeplens.ai

See what CB Insights has to offer

Founded Year

2017

Stage

Loan | Alive

Total Raised

$17.2M

About Deep Lens

Deep Lens is an AI company focused on identifying patients for clinical trials using VIPER, an AI-driven, digital pathology cloud platform which for over ten years has allowed pathology groups to collaborate on groundbreaking cancer research across dozens of cancer types.

Deep Lens Headquarter Location

1275 Kinnear Rd

Columbus, Ohio, 43212,

United States

614-453-1313

Latest Deep Lens News

Deep Lens and Southern Oncology Specialists Enter Strategic Partnership That Will Use AI-Based Solution VIPER™ to Improve Clinical Trial Matching

Oct 28, 2021

October 28, 2021 10:05 AM Eastern Daylight Time COLUMBUS, Ohio & CHARLOTTE, N.C.--( BUSINESS WIRE )-- Southern Oncology Specialists and Deep Lens today announced that they have entered into a strategic agreement that will use Deep Lens’ artificial intelligence (AI) based technology and other services to expand the practice’s clinical trial offering to patients. Southern Oncology Specialists offers comprehensive cancer care and serves patients in four locations in the greater Charlotte region. The practice is also a member of the Innovative Community Oncology Practices (ICOP), a collaboration of local oncology practices that work to improve and expand the scope of services in the community oncology setting through information sharing, educational activities and research. Deep Lens is a digital healthcare company that uses AI to accelerate clinical trial recruitment and enrollment for community oncology practices. This partnership will bring more precision medicine trials to the practice and broaden the practice’s existing research program. “Clinical research is critical to advancing the development of new therapies and accelerating our general understanding of the way specific diseases present and evolve in unique individuals,” said William R. Mitchell, MD, of Southern Oncology Specialists. “We are committed to giving our patients every resource possible to aggressively fight their disease. Expanding our clinical research program, attracting more trials to our practice and identifying the right trials for the right patients right as they are diagnosed will help our practice serve and support our patients more effectively as they progress down their treatment journey.” It is estimated that more than 15,000 oncology clinical trials are actively recruiting patients; however, fewer than 1 in 30 patients participate in a clinical trial. Limited trial site resources make it time-consuming to identify eligible patients, especially as trial protocols increase in complexity. VIPER supports care teams by automating the identification of potentially eligible patients at the time of diagnosis and easily matching them to relevant trials. “Most oncology clinical trials will fail because they cannot enroll enough patients. This is largely due to the increase in precision medicine trials, which frequently have complex eligibility criteria that can be challenging for a site to manage in the often very narrow window of time that is required,” said Tyrone Richardson, vice president, provider sales at Deep Lens. “Deep Lens services are designed to minimize the labor demands of the practice and ensure patients are matched immediately to the right trials, right upon diagnosis. The Southern Oncology team is a research-focused practice and we are delighted to collaborate with them to help support the expansion of their offering to patients now and in the future. We look forward to supporting their team, their practice and most importantly, the patients who deserve every opportunity to access novel new therapies in development.” Deep Lens’ VIPER will pre-screen all patients from Southern Oncology Specialists’ EMR (OncoEMR) and integrate molecular data feeds from Caris Life Sciences, Guardant Health, Foundation Medicine and Tempus as well as all pathology feeds to automatically identify qualified patients for clinical trials. The Deep Lens pre-screening and clinical trial matching solution is provided at no cost to oncology practices. Deep Lens is working with a significant number of community oncology practices representing every region in the U.S. It is estimated that approximately 85 percent of cancer patients are diagnosed and treated at local, community-based oncology practices. Deep Lens is committed to expanding important oncology research by making trials more accessible to a larger and more diverse population within these local community settings. About Southern Oncology Specialists Southern Oncology Specialists is a premier, comprehensive cancer practice serving patients throughout the Carolinas. The practice offers complete oncology and hematology care with onsite imaging, high complex CLIA certified laboratory, retail specialty pharmacy and state-of-the-art infusion services. Southern Oncology Specialists’ board-certified providers offer personalized, compassionate care for each patient, in a comfortable and convenient setting. For more information, visit: www.southernoncology.com . About Deep Lens Deep Lens is a digital healthcare company focused on a groundbreaking approach to faster recruitment of the best-suited cancer patients to clinical trials. VIPER, Deep Lens’ integrated cloud platform, provides care teams with visibility and workflows that combine lab, EMR, and genomic data to match cancer patients to clinical trials and precision therapies at the time of diagnosis, accelerating recruitment and compressing study timelines to bring game-changing therapies to market sooner. Growing with sponsors, providers, and strategic partners, Deep Lens challenges the status quo so that patients can get the best therapies. For more information, visit www.deeplens.ai . Contacts

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Deep Lens

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Deep Lens in 4 CB Insights research briefs, most recently on Oct 2, 2019.

Expert Collections containing Deep Lens

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Deep Lens is included in 5 Expert Collections, including Clinical Trials Tech.

C

Clinical Trials Tech

317 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

A

Artificial Intelligence

7,904 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

D

Digital Health 150

150 items

2019's cohort of the most promising digital health startups transforming the healthcare industry

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

D

Digital Health

11,293 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Deep Lens Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Deep Lens Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.